Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Clinical Laboratory Management(Electronic Edition) ›› 2014, Vol. 02 ›› Issue (02): 85-87. doi: 10.3877.cma.j.issn.2095-5820.2014.02.004

• Opinion • Previous Articles     Next Articles

Personal comments on the guideline of cholesterol treatment announced by ACC/AHA in 2013

Jianjun Li1,()   

  1. 1.Center for Dyslipidemia and Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing 100037, China
  • Received:2014-01-27 Online:2014-05-28 Published:2024-11-30
  • Contact: Jianjun Li

Abstract:

The American College of Cardiology (ACC) /American Heart Association (AHA) on November 12, 2013, announced the latest guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. In this new guideline update, much has changed in areas of human cholesterol management and this document contains new and revised recommendations. The paper here, by closely integrating with the experience of clinical practice in China, focused on the ACC/AHA guidelines important recommendations and then elabrated the personal comments based on the interpretation of the space arround me.

Key words: Lipidemia, Cholesterol, Guideline

京ICP 备07035254号-20
Copyright © Chinese Journal of Clinical Laboratory Management(Electronic Edition), All Rights Reserved.
Tel: 020-81341720 Fax: 020-37103505 E-mail: clinlab@cma.org.cn
Powered by Beijing Magtech Co. Ltd